ACCC takes health fund NIB to court over concealing changes to its MediGap Scheme

30 May 2017 - The consumer watchdog has taken health fund NIB to court, accusing it of concealing changes to ...

Read more →

Health Minister Greg Hunt shoots down department's secret hospital plan

29 May 2017 - Health department bosses have described their radical proposal to remake hospital funding as "future gazing" after ...

Read more →

UK’s NICE recommends Novartis’ Afinitor to treat neuroendocrine tumours

29 May 2017 - The UK’s NICE has recommended Novartis’ Afinitor (everolimus) to treat unresectable or metastatic neuroendocrine tumours in patients ...

Read more →

CADTH publishes final recommendations for two Servier medicines

25 May 2017 - CADTH has published outcomes for edoxaban tosylate (Lixiana) and ivabradine hydrochloride (Lancora). ...

Read more →

Leaked documents reveal secret plan for radical hospital overhaul

29 May 2017 - The private health insurance rebate would be abolished, consumers would be charged more for extras cover and ...

Read more →

Shock surgical costs around New Zealand

30 May 2017 - Leading health insurer heads effort to make surgery costs transparent & consistent. ...

Read more →

Draft report for the post-market review of COPD medicines

29 May 2017 - The draft report for the post-market review of chronic obstructive pulmonary disease medicines is available for ...

Read more →

IVF options for older women curtailed as government views Medicare costs

28 May 2017 - IVF options for older women curtailed as government views Medicare costs. ...

Read more →

US drug prices are so high that Canada wants other countries as reference points

22 May 2017 - How high are drug prices in the US? So high that the Canadian government may remove ...

Read more →

Conservatism and the cancer drugs fund

24 May 2017 - Are some patients—and some people— more deserving than others? ...

Read more →

Earlier access to new drugs could solve Canada's affordability crisis

23 May 2017 - Policymakers are fiercely debating how to tackle the soaring costs of prescription drugs in Canada.  ...

Read more →

Transparency Commission publishes its review of Keytruda's SMR & ASMR

22 May 2017 - The Transparency Commission has reviewed its SMR & ASMR ratings of pembrolizumab for malignant melanoma. ...

Read more →

CADTH recommends reimbursement of Gilead's Odefsey

25 May 2017 - The CADTH Canadian Drug Expert Committee has recommended that emtricitabine/rilpivirine/tenofovir alafenamide be reimbursed as a complete ...

Read more →

New medicines funding for breast cancer still elusive

25 May 2017 - The Breast Cancer Aotearoa Coalition (BCAC) welcomes new funding for the Government’s drug-buying agency, PHARMAC, but ...

Read more →

NICE terminates appraisal of afatinib dimaleate

24 May 2017 - NICE was to assess afatinib dimaleate for treatment of patients with advanced squamous non-small-cell lung cancer ...

Read more →